Cash flow quality is improving but remains volatile, with AFFO covering dividends by 2.2x in 2026Q2, up from 1.5x in 2024Q4, yet AFFO conversion is inconsistent, as evidenced by negative AFFO in 2024Q4 and significant quarterly swings in working capital.
American Healthcare REIT, Inc. (AHR) cash flow statement — 10-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 |
|---|
| Cash from Operations | 369.03M | 294.44M | 176.09M | 98.53M | 147.77M | 17.91M | 219.16M | 117.45M | 106.81M | 128.1M | 114.36M |
| Operating CF Growth % | 173.72% | 67.21% | 78.7% | -33.32% | 724.92% | -91.83% | 86.59% | 9.96% | -16.62% | 12.02% | - |
| Operating CF / Revenue % | 14.75% | 13.03% | 8.5% | 5.3% | 9.14% | 1.42% | 18.5% | 9.62% | 9.44% | 12.21% | 11.67% |
| Net Income | 121.02M | 70.82M | -35.6M | -76.89M | -73.38M | -53.27M | 2.16M | -4.96M | 13.3M | 11.22M | -146.03M |
| Depreciation & Amortization | 280.08M | 225.2M | 221.64M | 237.3M | 200.6M | 157.38M | 132.95M | 144.14M | 103.31M | 121.42M | 277.67M |
| Stock-Based Compensation | 19.5M | 14.62M | 9.87M | 5.47M | 3.91M | 9.66M | -1.19M | 2.96M | 3.24M | 1.2M | 1.82M |
| Other Non-Cash Items | -7.41M | 37.06M | 48.86M | -11.55M | 54.44M | -2.39M | 10.97M | 24.24M | 8.08M | 16.82M | -2M |
| Working Capital Changes | -21.12M | -30.32M | -68.68M | -55.79M | -37.8M | -93.47M | 74.19M | -48.92M | -21.12M | -22.57M | -17.09M |
| Cash from Investing | -1.36B | -1.08B | -8.73M | 9.4M | -118.58M | -138.65M | -147.94M | -103.11M | -135.77M | -124.55M | -352.69M |
| Acquisitions (Net) | -283.98M | -118.84M | -235K | -12.93M | -18.57M | -650K | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale of Investments | 46.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | -1.08B | -835.89M | 83.44M | 122.11M | -28.49M | -58.31M | -19.64M | -10.28M | -68.86M | -81M | -306.7M |
| Cash from Financing | 1.02B | 817.5M | -134.74M | -129.06M | -42.92M | 94.11M | -8.81M | 2.69M | 37.6M | 4.76M | 226.66M |
| Dividends Paid | -178.53M | -163.52M | -120.89M | -76.28M | -51.12M | -22.79M | -27M | -62.61M | -59.97M | -55.78M | -51.68M |
| Common Dividends | -178.53M | -163.52M | -120.89M | -76.28M | -51.12M | -22.79M | -27M | -62.61M | -59.97M | -55.78M | -51.68M |
| Debt Issuance (Net) | -4M | -1000K | -1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Share Repurchases | -9.76M | 238K | -14K | -469K | -20.7M | -382K | -23.11M | -89.89M | -76.58M | -30.66M | -20.94M |
| Other Financing | -9.73M | -4.98M | -382.64M | -34.72M | -33.93M | -29.04M | -724K | -17.98M | -8.42M | 1.71M | 9.77M |
| Net Change in Cash | 30.11M | 28.45M | 32.52M | -21.12M | -13.58M | -26.7M | 62.31M | 17.18M | 8.56M | 8.47M | -11.81M |
| Exchange Rate Effect | -89K | 62K | -91K | 7K | 154K | -74K | -90K | 145K | -77K | 149K | -140K |
| Cash at Beginning | 156.88M | 123.3M | 90.78M | 111.91M | 125.49M | 152.19M | 89.88M | 72.7M | 64.14M | 55.68M | 67.49M |
| Cash at End | 191.62M | 151.75M | 123.3M | 90.78M | 111.91M | 125.49M | 152.19M | 89.88M | 72.7M | 64.14M | 55.68M |
| Free Cash Flow | 261.84M | 165.88M | 84.15M | -1.26M | 76.25M | -61.78M | 90.85M | 24.62M | 39.91M | 84.55M | 68.37M |
| FCF Growth % | 71.04% | 97.13% | 6799.6% | -101.65% | 223.41% | -168% | 269.06% | -38.31% | -52.8% | 23.66% | - |
| FCF / Revenue % | 10.47% | 7.34% | 4.06% | -0.07% | 4.71% | -4.89% | 7.67% | 2.02% | 3.53% | 8.06% | 6.97% |
Quick answers to the most common questions about buying AHR stock.
American Healthcare REIT, Inc. (AHR) generated $294.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
American Healthcare REIT, Inc. (AHR) generated $165.9M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
American Healthcare REIT, Inc. (AHR) spent $128.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, American Healthcare REIT, Inc. (AHR) returned $163.5M to shareholders via cash dividends and spent $0.2M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Labor cost pressure on margins
Metrics are mathematically derived from official filings.
AFFO Coverage Strengthens but Remains Thin
AFFO covered dividends by 2.2x in 2026Q2, up from 1.5x in 2024Q4, as reported in the latest financials, but the buffer remains modest given volatile quarterly AFFO.
The dividend payout ratio improved to 0.46 in 2026Q2 from 1.51 in 2024Q4, indicating a significant reduction in dividend strain. However, AFFO has been erratic, with 2024Q4 showing negative AFFO, so the recent coverage may not be sustainable. Investors should monitor whether AFFO can consistently exceed dividends by a comfortable margin, especially as the company concentrates capital in senior housing.
Capex Intensity Reflects Operating Model
Capital expenditures averaged $38.5M per quarter over the last five quarters, with maintenance capex consuming a significant portion of FFO, as per the cash flow data.
The gap between FFO and AFFO, averaging $45M per quarter, highlights substantial recurring capex for tenant improvements and leasing commissions, typical for healthcare properties. This capex intensity is higher than triple-net peers, reflecting the operating nature of AHR's senior housing assets. The elevated capex may pressure AFFO growth if not offset by revenue gains.
Working Capital Swings Signal Timing Effects
Operating cash flow exceeded net income by $88M in 2026Q2, but quarterly swings in working capital have been volatile, as shown in the cash flow statement.
The large positive OCF relative to net income suggests non-cash items like depreciation and amortization are significant, but also that working capital changes are material. For instance, 2025Q3 saw OCF of $107M despite net income of $55.9M, while 2025Q1 had negative net income but positive OCF. These swings may reflect timing of rent collections and payables, warranting attention to tenant receivable quality.
Dividend Not Fully Covered by Internal Cash
In 2024Q4, dividends exceeded AFFO by 51%, indicating reliance on external sources, but by 2026Q2, AFFO covered dividends by 2.2x, per the cash flow data.
The improvement in dividend coverage suggests reduced dependency on external funding for distributions. However, the company's growth strategy may still require external capital, as evidenced by occasional negative FCF quarters. Monitoring the use of ATM programs or debt issuance will be key to assessing balance sheet strain.
Depreciation Distorts Earnings, FFO Provides Clarity
FFO exceeded net income by $72M in 2026Q2, underscoring the large depreciation charge on real estate assets, as reported in the financial statements.
The FFO-to-net-income ratio of 3.88 in 2026Q2 highlights the significant non-cash depreciation expense, which is typical for REITs. This distortion makes GAAP net income less relevant for valuation, and investors should focus on FFO and AFFO. The magnitude of depreciation is consistent with a heavy real estate asset base, but the volatility in FFO/NI across quarters suggests other non-cash items may also be at play.
Cash Flow Quality Warrants Scrutiny
Despite positive FFO, AFFO conversion has been inconsistent, with 2024Q4 AFFO negative, suggesting potential non-cash or non-recurring items inflating FFO, as per the cash flow data.
The wide gap between FFO and AFFO, averaging $45M per quarter, may indicate that a portion of FFO is not convertible to cash due to high maintenance capex. Additionally, the negative FCF in 2025Q4 and 2024Q1 raises questions about the sustainability of distributions. Investors should investigate the composition of FFO and the nature of capex to ensure cash flow quality is not overstated.